Autori: Schernthaner Guntram
| Naslov | Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes (Editorial Material) |
| Autori | Schernthaner Guntram ... Lalic Nebojsa M ... (broj koautora 17) |
| Info | CARDIOVASCULAR DIABETOLOGY, (2020), vol. 19 br. 1, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs (Editorial Material) |
| Autori | Schernthaner Guntram ... Lalic Katarina S  ... (broj koautora 17)
|
| Info | CARDIOVASCULAR DIABETOLOGY, (2019), vol. 18 br. 1, str. - |
| Projekat | Boehringer Ingelheim |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle (Editorial Material) |
| Autori | Schernthaner Guntram Wanner Christoph Jurisic-Erzen Dubravka Guja Cristian Gumprecht Janusz Jarek-Martynowa Iwona R Karasik Avraham Lalic Nebojsa M Mankovsky Boris N Prazny Martin Tankova Tsvetalina Tsur Anat Wascher Thomas C Wittmann Istvan |
| Info | DIABETES RESEARCH AND CLINICAL PRACTICE, (2019), vol. 153 br. , str. 30-40 |
| Projekat | Fortis Pharma Communications; Boehringer Ingelheim |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | SGLT2 inhibitors in T2D and associated comorbidities differentiating within the class (Letter) |
| Autori | Schernthaner Guntram Drexel Heinz Moshkovich Evgeny Zilaitiene Birute Martinka Emil Czupryniak Leszek Varkonyi Tamas Janez Andrej Ducena Kristine Lalic Katarina S Tankova Tsvetalina Prazny Martin Smircic-Duvnjak Lea Sukhareva Olga Sourij Harald
|
| Info | BMC ENDOCRINE DISORDERS, (2019), vol. 19 br. , str. - |
| Projekat | Boehringer Ingelheim (BI) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? (Editorial Material) |
| Autori | Schernthaner Guntram ... Lalic Nebojsa M ... (broj koautora 17) |
| Info | CARDIOVASCULAR DIABETOLOGY, (2018), vol. 17 br. , str. - |
| Projekat | Boehringer Ingelheim; medical communication agency Fortis Pharma Communications |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
